Opthea Limited (NASDAQ:OPT - Get Free Report) saw unusually-high trading volume on Friday . Approximately 84,166 shares were traded during mid-day trading, an increase of 204% from the previous session's volume of 27,659 shares.The stock last traded at $4.87 and had previously closed at $4.60.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group upgraded Opthea to a "strong-buy" rating in a report on Tuesday, December 17th.
Read Our Latest Analysis on OPT
Opthea Stock Up 6.3 %
The company has a 50 day moving average of $3.64 and a 200-day moving average of $3.47.
Institutional Trading of Opthea
A hedge fund recently bought a new stake in Opthea stock. Twin Lakes Capital Management LLC acquired a new stake in shares of Opthea Limited (NASDAQ:OPT - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 19,806 shares of the company's stock, valued at approximately $81,000. Institutional investors own 55.95% of the company's stock.
About Opthea
(
Get Free Report)
Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
See Also
Before you consider Opthea, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Opthea wasn't on the list.
While Opthea currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
